NM_014141.6:c.98-103822C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.98-103822C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.809 in 152,038 control chromosomes in the GnomAD database, including 50,345 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 50345 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.498

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.885 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.98-103822C>T intron_variant Intron 1 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.98-103822C>T intron_variant Intron 1 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.98-103822C>T intron_variant Intron 1 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000625365.2 linkc.98-103822C>T intron_variant Intron 2 of 3 5 ENSP00000485955.1 A0A0D9SES4
CNTNAP2ENST00000637150.1 linkn.27-103822C>T intron_variant Intron 1 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.809
AC:
122913
AN:
151920
Hom.:
50329
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.843
Gnomad AMI
AF:
0.913
Gnomad AMR
AF:
0.598
Gnomad ASJ
AF:
0.845
Gnomad EAS
AF:
0.704
Gnomad SAS
AF:
0.907
Gnomad FIN
AF:
0.907
Gnomad MID
AF:
0.761
Gnomad NFE
AF:
0.819
Gnomad OTH
AF:
0.792
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.809
AC:
122976
AN:
152038
Hom.:
50345
Cov.:
31
AF XY:
0.809
AC XY:
60092
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.843
AC:
34956
AN:
41476
American (AMR)
AF:
0.597
AC:
9119
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.845
AC:
2929
AN:
3468
East Asian (EAS)
AF:
0.705
AC:
3630
AN:
5152
South Asian (SAS)
AF:
0.907
AC:
4376
AN:
4824
European-Finnish (FIN)
AF:
0.907
AC:
9581
AN:
10560
Middle Eastern (MID)
AF:
0.753
AC:
220
AN:
292
European-Non Finnish (NFE)
AF:
0.819
AC:
55662
AN:
67982
Other (OTH)
AF:
0.793
AC:
1670
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1147
2294
3442
4589
5736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
874
1748
2622
3496
4370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.790
Hom.:
8432
Bravo
AF:
0.785
Asia WGS
AF:
0.809
AC:
2816
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
10
DANN
Benign
0.81
PhyloP100
0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2642515; hg19: chr7-146367541; API